Drugs / Anti-PSMA Designer T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01929239 | Mar 2006 → Dec 2017 | — | Roger Williams Medical Center | Suspended | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-PSMA Designer T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01929239 ↗ |
| Modality | Cell therapy | “The T cells are collected by pheresis and then genetically modified” NCT01929239 ↗ |